Physician
Rheumatology
Dr. Alfonso E. Bello, MD
|
|
Give Review
Alfonso Bello practices Rheumatology. He graduated from University of Illinois College of Medicine. He over the years received 2 awards: "Fellow (FACR)" and "Fellow (FACP)". Doctor Alfonso E. Bello, MD is a published physician as well. He has 15 publications published. The latest was: Comparison of synovial fluid cartilage marker concentrations and chondral damage assessed arthroscopically in acute knee injury.
Publications
- 1-year safety of ibuprofen/famotidine fixed combination versus ibuprofen alone: pooled analyses of two 24-week randomized, double-blind trials and a follow-on extension.
- One-year open-label safety evaluation of the fixed combination of ibuprofen and famotidine with a prospective analysis of dyspepsia.
- Cardiovascular Risk with Non-steroidal Anti-inflammatory Drugs: Clinical Implications.
- Risk of upper gastrointestinal ulcers in patients with osteoArthritis receiving single-tablet Ibuprofen/Famotidine versus Ibuprofen alone: pooled efficacy and safety a...
- DUEXIS((R)) (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic Pain and inflammation who require treatment with a non...
- Double-Blind Randomized Trials of Single-Tablet Ibuprofen/High-Dose Famotidine vs. Ibuprofen Alone for Reduction of Gastric and Duodenal Ulcers.
- Collagen hydrolysate for the treatment of osteoArthritis and other joint disorders: a review of the literature.
- COX-2 specific inhibitors in the management of osteoArthritis of the knee: a placebo-controlled, randomized, double-blind study.
- Celecoxib versus naproxen and diclofenac in osteoArthritis patients: SUCCESS-I Study.
- Cyclooxygenase-2 specific inhibitors and upper gastrointestinal tolerability in patients with osteoArthritis receiving concomitant low dose aspirin: pooled analysis of...
- Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoArthritis.
- Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoArthritis patients.
- Immunologic tolerability profile of celecoxib.
- Comparison of synovial fluid cartilage marker concentrations and chondral damage assessed arthroscopically in acute Knee injury.
Schools
University Of Illinois College Of Medicine Chicago
Procedures Preformed
- Epidural Block, Facet Blocks
- Epidural Steroid Injections
- Joint Drainage
- Joint Injection
- View All
Conditions Treated
- Achilles Tendinitis
- Adhesive Capsulitis
- Ankylosing Spondylitis
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Pain Medicine
- Rheumatology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Assurant Health
- Blue Card PPO
- Blue Choice
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- CoreSource
- Coventry Health Care of Illinois PPO
- Health and Life PPO
- Platinum PPO
- Coventry Health Care of Missouri PPO
- First Health (Coventry Health Care) PPO
- Medicare Advantage PFFS
- HealthLink PPO
- HealthPartners
- Choice Care PPO
- Preferred PPO
- Medical Mutual of Ohio
- Medicare MCR
- Meritain Health
- MultiPlan PPO
- PHCS Network PPO
- MVP Health Care
- Pipefitters
- Priority Health
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Fellow (FACR)
- Fellow (FACP)
Education
-
Duke University Hospital -
Duke University -
Advocate Lutheran General Hospital -
University of Illinois College of Medicine
Hospital
-
NorthShore University Health System -
Advocate Lutheran General Hospital
Drug Facts
| NPI NUMBER | 1942252697 | |
| NPPES Provider LastName | BELLO | |
| NPPES Provider FirstName | ALFONSO | |
| NPPES Provider ZIPCode | 600257645 | |
| NPPES Provider State | IL | |
| Specialty Description | Rheumatology | |
| Total Claim Count | 2820.0 | |
| Distinct Opioid Count | 9.0 | |
| Opioid Claim Count | 642.0 | |
| Percent Opioid Claims | 22.77 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1942252697 |
| Last Name Of The Provider | BELLO |
| First Name Of The Provider | ALFONSO |
| View All |